US Patent Issued to The Regents of the University of California on Sept. 16 for "Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer" (California Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,843, issued on Sept. 16, was assigned to The Regents of the University of California (Oakland, Calif.).

"Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer" was invented by John Matthew Timmerman (Los Angeles), Reiko King (Los Angeles), Patricia Young (Los Angeles), Alex Vasuthasawat (Los Angeles), Kham M. Trinh (Alhambra, Calif.) and Sherie Leaver Morrison (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "In various embodiments methods are provided that involve the use of antibody-interferon (Ab-IFN) fusion proteins to boost the cancer-fighting capacity of adoptive T cell therapies (AC...